Cargando…
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine
Oncolytic Viruses (OVs) work through two main mechanisms of action: the direct lysis of the virus-infected cancer cells and the release of tumor antigens as a result of the viral burst. In this sc.enario, the OVs act as in situ cancer vaccines, since the immunogenicity of the virus is combined with...
Autores principales: | Feola, Sara, Russo, Salvatore, Martins, Beatriz, Lopes, Alessandra, Vandermeulen, Gaëlle, Fluhler, Vinciane, De Giorgi, Camilla, Fusciello, Manlio, Pesonen, Sari, Ylösmäki, Erkko, Antignani, Gabriella, Chiaro, Jacopo, Hamdan, Firas, Feodoroff, Michaela, Grönholm, Mikaela, Cerullo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047942/ https://www.ncbi.nlm.nih.gov/pubmed/35493448 http://dx.doi.org/10.3389/fimmu.2022.826164 |
Ejemplares similares
-
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2023) -
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021) -
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
por: Feola, Sara, et al.
Publicado: (2022) -
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
por: Hamdan, Firas, et al.
Publicado: (2021) -
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
por: Fusciello, Manlio, et al.
Publicado: (2022)